Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A guide for assessing pharmacoepidemiologic studies.

M A Levine1

  • 1Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.

Pharmacotherapy
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the Periodontitis-Diabetes Linkage: Mechanisms and Evidence.

Journal of dental research·2025
Same author

Clinical evaluation and molecular analysis of genetic and epigenetic inactivation defects in GNAS in children: A multicenter experience in China.

European journal of endocrinology·2025
Same author

Multicentric Carpotarsal Osteolysis: a Contemporary Perspective on the Unique Skeletal Phenotype.

Current osteoporosis reports·2022
Same author

A novel dominant COL11A1 mutation in a child with Stickler syndrome type II is associated with recurrent fractures.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

The Internal Medicine Subinternship--Now More Important than Ever: A Joint CDIM-APDIM Position Paper.

Journal of general internal medicine·2015
Same author

A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC).

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
Same journal

Voriconazole Dosing and Therapeutic Drug Monitoring in Patients Before and After Liver Transplantation.

Pharmacotherapy·2026
Same journal

Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients.

Pharmacotherapy·2026
See all related articles

Pharmacoepidemiology studies link common drugs to rare adverse events. Clinicians must critically appraise this evidence, considering potential biases in nonexperimental designs, before changing practice.

Area of Science:

  • Clinical Pharmacology
  • Pharmacoepidemiology
  • Drug Safety

Background:

  • Pharmacoepidemiologic studies are increasingly published, reporting associations between common medications and rare adverse clinical events.
  • These studies often use nonexperimental designs, which can introduce potential biases.

Purpose of the Study:

  • To provide guidance for critically appraising literature on adverse drug effects.
  • To emphasize the importance of evaluating biases in pharmacoepidemiologic research.
  • To advise practitioners on assessing causality and practice changes based on these studies.

Main Methods:

  • The abstract outlines a critical appraisal process for evaluating pharmacoepidemiologic studies.
  • It highlights the need to assess potential biases inherent in nonexperimental study designs.

Related Experiment Videos

  • It also stresses the importance of considering the consequences of not using a drug.

    • Main Results:

    • The critical appraisal process should involve evaluating the justification of causality claims.
    • Understanding potential biases in nonexperimental studies is crucial for accurate interpretation.
    • Assessing the implications of avoiding a drug linked to adverse effects is essential.

    Conclusions:

    • Practitioners should critically appraise pharmacoepidemiologic evidence before altering clinical practice.
    • Evaluating study biases, particularly in nonexperimental designs, is paramount.
    • A balanced consideration of drug benefits versus risks is necessary when interpreting adverse event associations.